Rocket Pharmaceuticals Inc (RCKT)

Rocket Pharmaceuticals Inc (RCKT) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $239M; returns 1 day -0.9%, 1 week +5.0%, 1 year -38.8%.

Rocket Pharmaceuticals Inc. (RCKT) is a fully integrated, late-stage biotechnology company focused on developing and commercializing gene therapies for rare and devastating diseases. The company employs both adeno-associated viral (AAV) and lentiviral vector (LVV) approaches to gene therapy.

Groups RCKT belongs to

• Biotechnology
• Gene Therapy
• Rare Diseases
• Clinical Stage Biotech
• Biopharmaceutical
• Healthcare
• Life Sciences
• Clinical Stage

RCKT financial model: income statement, cash flow and balance sheet